https://kanna.clinic Educational botanical reference for kanna — not a clinic or supplier en-US https://kanna.clinic/blog/2026-07-21-access-and-benefit-sharing-explained/ https://kanna.clinic/blog/2026-07-21-access-and-benefit-sharing-explained/ Tue, 21 Jul 2026 00:00:00 GMT A plain-language intro to Nagoya Protocol ABS, South African biodiversity context, and why ‘wild-harvested kanna’ without paperwork is an ethical and quality red flag. https://kanna.clinic/blog/2026-07-21-fermented-vs-raw-kanna-alkaloid-profile/ https://kanna.clinic/blog/2026-07-21-fermented-vs-raw-kanna-alkaloid-profile/ Tue, 21 Jul 2026 00:00:00 GMT Traditional kougoed is fermented; many modern products are not. Here is what published chemistry implies about mesembrine-class shifts — without recipes or doses. https://kanna.clinic/blog/2026-07-21-how-to-read-a-kanna-extract-label/ https://kanna.clinic/blog/2026-07-21-how-to-read-a-kanna-extract-label/ Tue, 21 Jul 2026 00:00:00 GMT A buyer-education checklist for Sceletium products: species, assay markers, solvents, fermentation, COAs, and disease-claim red flags — without brand rankings or doses. https://kanna.clinic/blog/2026-07-21-kanna-and-ssris-what-we-know/ https://kanna.clinic/blog/2026-07-21-kanna-and-ssris-what-we-know/ Tue, 21 Jul 2026 00:00:00 GMT Why in vitro serotonin-reuptake activity raises interaction questions with SSRIs and other serotonergic drugs — and why controlled human combination data are still missing. https://kanna.clinic/blog/2026-07-21-zembrin-cognition-trial-what-it-showed/ https://kanna.clinic/blog/2026-07-21-zembrin-cognition-trial-what-it-showed/ Tue, 21 Jul 2026 00:00:00 GMT A plain-language reading of the Chiu et al. 2014 standardized Sceletium extract study: population, outcomes, limits, and why it is not an FDA approval or a dosing guide. https://kanna.clinic/blog/2026-05-30-what-is-kanna-plain-english-guide-2026/ https://kanna.clinic/blog/2026-05-30-what-is-kanna-plain-english-guide-2026/ Sat, 30 May 2026 00:00:00 GMT A clear, factual introduction to kanna (Sceletium tortuosum) — what it is, where it comes from, how it works, and what the current evidence base looks like. https://kanna.clinic/blog/2026-05-29-kanna-vs-ketamine-how-they-differ/ https://kanna.clinic/blog/2026-05-29-kanna-vs-ketamine-how-they-differ/ Fri, 29 May 2026 00:00:00 GMT A side-by-side comparison of kanna and ketamine — two very different substances that both attract interest in the mental wellness space, with distinct legal status and evidence bases. https://kanna.clinic/blog/2026-05-28-kanna-regulatory-status-us-2026/ https://kanna.clinic/blog/2026-05-28-kanna-regulatory-status-us-2026/ Thu, 28 May 2026 00:00:00 GMT Where kanna stands legally in the US in 2026 — not scheduled, sold as a supplement, but with real questions about labeling, marketing claims, and import compliance.